Recent work from several laboratories has shown that, in contrast to t
he widely held notion that one autoimmune disease is caused by one or
a few related autoantigenic determinants, autoimmunity is fundamentall
y a continuously evolving process. The autoimmune responses shift, dri
ft and diversify with time not only to other determinants in the origi
nal antigen but also to other antigens. We have described a form of de
terminant spreading - reciprocal T-B determinant spreading - where the
induction of first T cells by peptides from an autoantibody molecule
could lead to help provided to a variety of B cells displaying a cross
-reactive version of the original determinant. The response spreads in
this way by reciprocal T-B stimulation until large cohorts of T and B
cells have expanded. Such spontaneous expansion must be important in
clinical disease, since tolerance induction to a limited set of T-cell
determinant peptides derived from an anti-DNA antibody V-H region del
ayed the appearance of IgG anti-dsDNA antibodies and onset of lupus ne
phritis in the NZB/NZW F1 mouse model of systemic lupus erythematosus.
Understanding the diversification patterns in autoimmune responses ha
s enormous implications in developing peptide-targeted therapies.